BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 9722074)

  • 1. Successful double autografts for patients with relapsed clear cell sarcoma of the kidney.
    Yumura-Yagi K; Inoue M; Wakabayashi R; Mabuchi S; Nakayama M; Yoneda A; Imura K; Kawa-Ha K
    Bone Marrow Transplant; 1998 Aug; 22(4):381-3. PubMed ID: 9722074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of recurrent clear cell sarcoma of the kidney with brain metastasis.
    Radulescu VC; Gerrard M; Moertel C; Grundy PE; Mathias L; Feusner J; Diller L; Dome JS
    Pediatr Blood Cancer; 2008 Feb; 50(2):246-9. PubMed ID: 17226850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of duration of treatment on treatment outcome for patients with clear-cell sarcoma of the kidney: a report from the National Wilms' Tumor Study Group.
    Seibel NL; Li S; Breslow NE; Beckwith JB; Green DM; Haase GM; Ritchey ML; Thomas PR; Grundy PE; Finklestein JZ; Kim T; Shochat SJ; Kelalis PP; D'Angio GJ
    J Clin Oncol; 2004 Feb; 22(3):468-73. PubMed ID: 14752069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful management of a child with clear cell sarcoma of the kidney (CCSK) and multifocal bone metastases at diagnosis.
    Hempel L; Sauerbrey A; Zintl F; Weirich A; Lemmer A; Graf N
    Med Pediatr Oncol; 2003 Jul; 41(1):97-9. PubMed ID: 12764765
    [No Abstract]   [Full Text] [Related]  

  • 5. Adult clear cell sarcoma of the kidney: a case report.
    Kural AR; Onal B; Ozkara H; Cakarir C; Ayan I; Agaoglu FY
    BMC Urol; 2006 Apr; 6():11. PubMed ID: 16584570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clear cell sarcoma of the kidney. A study of 13 cases].
    El Kababri M; Khattab M; El Khorassani M; Hessissen L; Kili A; Nachef MN; Cherradi N; Malihy A; Alhamany Z; Msefer-Alaoui F
    Arch Pediatr; 2004 Jul; 11(7):794-9. PubMed ID: 15234374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-dose chemotherapy (HDC) and autologous hematopoietic stem cell transplantation (ASCT) as salvage therapy for relapsed osteosarcoma.
    Sauerbrey A; Bielack S; Kempf-Bielack B; Zoubek A; Paulussen M; Zintl F
    Bone Marrow Transplant; 2001 May; 27(9):933-7. PubMed ID: 11436103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-dose chemotherapy with autologous stem cell rescue in children with nephroblastoma.
    Kremens B; Gruhn B; Klingebiel T; Hasan C; Laws HJ; Koscielniak E; Hero B; Selle B; Niemeyer C; Finckenstein FG; Schulz A; Wawer A; Zintl F; Graf N
    Bone Marrow Transplant; 2002 Dec; 30(12):893-8. PubMed ID: 12476282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A feasibility study of multiple cycle therapy with melphalan, thiotepa, and paclitaxel followed by mitoxantrone, thiotepa, and paclitaxel with autologous hematopoietic cell support for metastatic breast cancer.
    Hu WW; Long GD; Stockerl-Goldstein KE; Johnston LJ; Chao NJ; Negrin RS; Blume KG
    Clin Cancer Res; 1999 Nov; 5(11):3411-8. PubMed ID: 10589752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dose-dependent effect of etoposide in combination with busulfan plus cyclophosphamide as conditioning for stem cell transplantation in patients with acute myeloid leukemia.
    Kröger N; Zabelina T; Sonnenberg S; Krüger W; Renges H; Stute N; Finkenstein F; Mayer U; Holstein K; Fiedler W; Colberg H; Sonnen R; Kuse R; Braumann D; Metzner B; del Valle F; Erttmann R; Kabisch H; Zander AR
    Bone Marrow Transplant; 2000 Oct; 26(7):711-6. PubMed ID: 11042650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clear-cell sarcoma of the kidney: the clinico-morphological, immunohistochemical and electron microscopic study of 22 cases].
    Smirnov AV; Sokolova IN; Volkova LD
    Arkh Patol; 1993; 55(2):31-8. PubMed ID: 7980060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-dose thiotepa, busulfan, cyclophosphamide and ASCT without whole-brain radiotherapy for poor prognosis primary CNS lymphoma.
    Cheng T; Forsyth P; Chaudhry A; Morris D; Glück S; Russell JA; Stewart DA
    Bone Marrow Transplant; 2003 Apr; 31(8):679-85. PubMed ID: 12692608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical treatment and prognosis for clear cell sarcoma: analysis of 19 cases].
    Yu SJ; Zhao ZG; Zang L; Lu HZ; Zhang HT; Xu L
    Zhonghua Yi Xue Za Zhi; 2008 Jun; 88(21):1458-61. PubMed ID: 18953850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of relapsed Wilms' tumor with high-dose therapy and autologous hematopoietic stem-cell rescue: the experience at Children's Memorial Hospital.
    Campbell AD; Cohn SL; Reynolds M; Seshadri R; Morgan E; Geissler G; Rademaker A; Marymount M; Kalapurakal J; Haut PR; Duerst R; Kletzel M
    J Clin Oncol; 2004 Jul; 22(14):2885-90. PubMed ID: 15254057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of high-dose busulfan plus melphalan as consolidation in metastatic Ewing tumors: a study by the Société Française des Cancers de l'Enfant.
    Oberlin O; Rey A; Desfachelles AS; Philip T; Plantaz D; Schmitt C; Plouvier E; Lejars O; Rubie H; Terrier P; Michon J;
    J Clin Oncol; 2006 Aug; 24(24):3997-4002. PubMed ID: 16921053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The dismal outcome in patients with acute leukaemia who relapse after an autograft is improved if a second autograft or a matched allograft is performed. Acute Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT).
    Ringdén O; Labopin M; Gorin NC; Meloni G; Blaise D; Reiffers J; Carlson K; Fouillard L; Frassoni F
    Bone Marrow Transplant; 2000 May; 25(10):1053-8. PubMed ID: 10828865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-dose busulfan/melphalan as conditioning for autologous PBPC transplantation in pediatric patients with solid tumors.
    Diaz MA; Vicent MG; Madero L
    Bone Marrow Transplant; 1999 Dec; 24(11):1157-9. PubMed ID: 10642802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-dose therapy for patients with primary multifocal and early relapsed Ewing's tumors: results of two consecutive regimens assessing the role of total-body irradiation.
    Burdach S; Meyer-Bahlburg A; Laws HJ; Haase R; van Kaik B; Metzner B; Wawer A; Finke R; Göbel U; Haerting J; Pape H; Gadner H; Dunst J; Juergens H
    J Clin Oncol; 2003 Aug; 21(16):3072-8. PubMed ID: 12915596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clear cell sarcoma of kidney (CCSK)--a clinicopathological study of 4 cases.
    Chellam VG; Chacko E; Kusumakumary P; Surendran
    Indian J Cancer; 1989 Jun; 26(2):120-8. PubMed ID: 2591997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anaplastic variant of clear cell sarcoma of the kidney: a rare case report.
    Kukreja M; Kamal M; Iyer VK; Mannan AA; Agarwal S
    Gulf J Oncolog; 2010 Jul; (8):55-8. PubMed ID: 20601342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.